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Background: The COVID-19 pandemic has had far-reaching societal and financial consequences. The
purpose of this study was to evaluate how COVID-19 has affected AAHKS industry partners and the
surgeon-industry relationship, emphasizing education, resource allocation, and strategic direction for the
2nd half of 2020.
Methods: AAHKS industry partners were contacted to participate in a blinded survey and optional
interview with the AAHKS Industry Relations Committee. Based on the results, a group of AAHKS
member surgeons with disparate practice types were asked to postulate on how the COVID-19 pandemic
has and will affect their practice and relationship with Industry.
Results: AAHKS industry partner responses indicated decreased resource allocation for regional, “other
national,” and AAHKS annual meetings (67%, 55%, and 30%, respectively). Web-based educational content
was expected to increase in 2020 and will likely remain a point of emphasis in 2021 (100% and 70% of
responders). For Q3/Q4 2020, a significant emphasis was placed on site of service/outpatient TJA and
COVID-19-related safety measures (70% and 90% of responders), as well as increased availability of
instrumentation and implants (40% and 60%, respectively).
Conclusion: The COVID-19 pandemic has altered the orthopedic landscape for the foreseeable future.
Survey responses by AAHKS industry partners demonstrate a continued commitment to surgeon edu-
cation with and increasing shift to a web-based platform. Increased resource allocation for outpatient TJA
and COVID-19-related safety measures were significant. Articulating optimal mechanisms to aid industry
in supporting surgeons with different practice models to meet demand during the second half of fiscal
year 2020 will be critical.
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reet, Suite 2000, Fishers, INThe orthopedic practice of AAHKS members, like virtually every
other industry in the United States, has been significantly burdened
by the negative economic effects of the worldwide COVID-19
pandemic. Elective cases have been essentially eliminated. Frac-
ture cases have slowed, and clinic visits have dropped by asmuch as
40-90 percent because of social distancingdall of which have
contributed to significant strain on orthopedic practices.
The cessation of elective total hip and knee arthroplasty has also
had a dramatic effect on AAHKS industry partners. Severe dips in
1st and 2nd quarter implant sales revenue have forced companies
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during these uncertain times. The significant financial resources
AAHKS industry partners have historically committed to support
national and regional orthopedic meetings, surgeon education,
clinical research, surgical/vendor operative room (OR) support, and
technological innovation have required redistribution to varying
degrees to maintain fiscal solvency.
Forecasts for when the US elective procedures may resume
suggest that inpatient procedures could potentially restart in some
states bymid-May, andmost if not all states by the end of June 2020
[1]. Hospitals, orthopedic groups, and Industry must create strate-
gies to address the anticipated increases in demand expected on a
return to “normalcy”. In the near term, it will be critical to meet
volumetric demands, support the orthopedic workforce, and create
more efficient business relationships to maintain continuity in a
rapidly changing milieu. Orthopedic practice models of AAHKS
members differ significantly and will be affected to varying extents
moving forward; the ability to increase production during the 2nd
half of the fiscal year for the private practice, academic, and
hospital-employed surgeon must be considered both separately
and collectively; needs in terms of optimal industry support will be
heterogeneous. Owing to the rapidly changing environment and
risk of a resurgent COVID-19 virus, long-term strategies must also
be articulated to safely prevent another catastrophic full-scale
shutdown of elective cases.Methods
Executive leadership of AAHKS industry partners with a signif-
icant footprint in elective hip and knee arthroplasty were contacted
to participate in a brief blinded survey (Table 1) and optional phone
or Zoom interviewwith a member of the AAHKS Industry RelationsTable 1
Insustry Survey.
AAHKS Industry Partner Survey: COVID-19 Response
In response to the COVID-19 pandemic and shutdown of elective hip and knee arthrop
Resources Designated for Orthopedic Meetings (Increase, Decrease, No Change, Uncert
AAHKS Annual Meeting
AAHKS Spring Meeting
Other National Meetings
Regional Meetings
Resources designated for surgeon education (increase, decrease, no change, uncertain)
Resident
Fellow
Surgeon
Hands on Cadaveric
Web-Based Recorded Video Education/Teaching
Web-Based Live Video Education/Training
Resources designated for strategic points of emphasis (increase, decrease, no change, u
Technology (Robotics, Navigation, etc)
Product R&D
Marketing
Outpatient Joint Arthroplasty
COVID-19-Related Operative Safety Measures
How has the shutdown of elective arthroplasty cases affected your workforce? (Some ha
the above, no change)
Implant Production Employees
Sales Representative Employees
R&D Employees
Marketing Employees
There is an anticipated surge of elective arthroplasty surgical volume in Q3/Q4 2020;
resources? (increase, decrease, no change, uncertain)
Instrumentation/Pan Sets
Implant Production
Sales WorkforceCommittee. The survey consisted of questions covering 5 topics to
gauge changes in industry support resource allocation and work-
force including: resources designated for orthopedic meetings, re-
sources designated for surgeon education, resources designated for
strategic points of emphasis, effect on industry workforce, and
measures taken to meet increased 3rd and 4th quarter demand.
Results were tabulated and distributed a cohort of AAHKS
member surgeons with disparate practice models including, private
practice, “academic” practice, and hospital-employed practice.
Surgeons were asked to consider these results and postulate on
how the COVID-19 pandemic has and will affect their specific
practice type and relationship with Industry in 2020 and beyond.Results
Executive leadership of AAHKS industry partners with a signif-
icant footprint in primary elective total hip and total knee arthro-
plasty were contacted to participate in the survey. Ten responses
were received, whereas 2 declined to participate (83%). Full survey
results are listed in Figure 1Resources Designated for Orthopedic Meeting Participation
Industry partners noted an expected shift in 2020 toward
decreased resources designated for orthopedic meeting participa-
tion across the board, with responding companies noting decreased
support for regional meetings (67%), as well as “other national
meetings” (55%), and to a lesser extent the AAHKS Annual Meeting
(30%). Uncertainty with respect to orthopedic meeting resource
allocation persisted among a small but significant percentage of
responders for 2021 (20%-33%), while most responders anticipated
a return to standard levels of support (50%-78%). Of responders,lasty in the United States, how has your company modified the following?
ain)
Q3/Q4 2020 2021
Q3/Q4 2020 2021
ncertain)
Q3/Q4 2020 2021
ve been let go, some have been furloughed, hours have been cut, more than one of
What if any measures are being taken to meet the potential increased demand of
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Annual Meeting in 2021.
Resources Designated for Surgeon Education
Twenty percent of responding companies anticipated decreased
budgeting for resident-, fellow-, and surgeon-specific educational
activities in 2020; this was tempered by an across the board in-
crease in web-based recorded and live video educational content
(100%). Industry support with educational resources in 2021 can be
expected to rebound for resident (40%), fellow (40%) and surgeon
(50%) education based on survey responses. Support for web-based
live and recorded content was also expected to again increase in
2021 (70%).
Resources Designated for Strategic Points of Emphasis
The most significant trends identified for resources designated
for strategic points of emphasis included a decrease in marketing
allocation (60% in 2020), and increased allocation for site of service/
outpatient joint arthroplasty and COVID-19-related operative
safety measures (70% and 90% of responders in 2020, 70% and 50%
in 2021).
Measures Taken to Meet Increased 3rd and 4th Quarter Demand
In anticipation of a Q3/Q4 2020 surge in elective joint arthro-
plasty, 90% of responding industry partners anticipated no signifi-
cant decrease in their sales workforce. Resources designated to
increase available instrumentation and support implant production
was expected to increase (40% and 50%, respectively) or remain
unchanged (60% and 40%, respectively). No industry partner
anticipated decreases in instrumentation, implant production, or
sales workforce during the fiscal year 2020.
Discussion
Industry support for AAHKS membership has played a critical
role driving success of orthopedics in general, and elective hip and
knee arthroplasty in specific. Resources directed toward the
training of residents, fellows, and surgeons have improved educa-
tional offerings. Industry vendor support in the operative room and
through implant development have enhanced operative efficiency
and improved patient outcomes. The surgeon-industry relationship
has become symbiotic to the point where both sides contribute to
financial success and viability of a health care system which pro-
vides access to quality orthopedic care for the American public. An
improved understanding of how the COVID-19 pandemic has
affected AAHKS industry partners and enhanced communication
will help optimize our combined response as a profession to un-
charted waters ahead. The survey and interview responses pro-
vided by AAHKS industry partners varied considerably; however,
strong common themes of continued commitment to education, as
well as the expectation for elevated levels of vendor/surgical sup-
port in the 2nd half of 2020 emerged.
Indirect Education Support: National and Regional Meetings
Industry partners expressed trepidation in their support of
regional meetings in 2020 (67% decrease) and a level of uncertainty
with regard to the 2020 AAHKS Annual Meeting (30% uncertain,
30% decreased resource allocation). Continued commitment to
support for the AAHKS Annual Meeting in 2021, however, was
strong (50% no change, 30% increase). This critical continued
resource allocation moving forward indirectly supports theeducational mission of our largest arthroplasty society. The extent
to which COVID-19 and associated societal scars lingers may very
well affect the scope, scale, attendance, and importance of all in
person regional and national orthopedic meetings for the foresee-
able future.Direct Education Support
In terms of direct support to surgeon education, a small
downtrend of support at each level of training was identified for
2020; however, a unanimous increase in resources directed toward
web-based educational platforms was seen which can potentially
benefit all learners. This included 100% of responders directing
more resources toward web-based recorded and live video
educational content in 2020. As physicians are forced to embrace
and become comfortable with telemedicine secondary to COVID-
19-induced social distancing, remote engagement and education
supported by our industry partners may become a mainstay to
reach a large number of individuals without geographic or tem-
poral limitations in a cost- and time-efficient manner.Surgical Support During 3rd and 4th Quarter 2020
A common theme across survey responses and phone in-
terviews was a significant commitment to enhanced surgeon sup-
port during the anticipated uptick of elective arthroplasty
procedure in the second half of the fiscal year. While AAHKS in-
dustry partners nearly universally articulated an assurance to
partner with surgeons to meet increased need, there is significant
uncertainly on how to distribute limited resources and optimally
support disparate surgeon practice models. Defining the needs of
AAHKSmembers with different practice models and articulating an
appropriate response will allow our industry partners to help
smooth the transition back to the OR for all arthroplasty surgeons.
Industry partners are working to prepare for the expected surge in
demand and appear open to guidance. This is a potential action
item for AAHKS and national leadership as we look to the future in
2020 and beyond.
Of industry responders, 70% expected to allocate more resources
to “site of service” support such as outpatient joint arthroplasty in
both 2020 and 2021. COVID-19-related operative safety measures
were also a highly emphasized (90% and 50% in 2020 and 2021,
respectively). As this first wave of COVID-19 tamponades, the ex-
pected surge of elective cases currently backloggedwill likely entail
maximally stressing the elective capabilities in certain centers; the
needs will be varied and inherently dependent on surgeon practice
model. Both sides of the aisle of our profession are currently bracing
for the possibility of extended weekday schedules and/or weekend
elective schedules where none existed prior. There will be
increased emphasis on efficiency of the nonsurgical aspects of
cases: pre-op preparation, anesthesia time, turnover times in the
OR, etc. Surgical efficiency will also be stressed, yet hopefully
maintaining its rightful place behind quality and safety. Our rela-
tionship with industry and our implant vendors can play a critical
role during this time.
On the vendor side, there could be a significantly greater tug of
war for implant reps to be present in multiple hospitals or surgery
centers at once, even late into the evenings or on weekends. More
instrument sets may be needed to do more of the same case per
day, or on consecutive days. As such, central sterilization efforts will
heavily be put to the test as well. Refill of implants will be
demandedmore quickly, andmore individual units of the same size
will be expected to be available at once, to work through the
backlog. We expect that the hip and knee implant manufacturers
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have been reduced for 3 months or more.
Private Practice Perspective
Amid the current shutdown of elective arthroplasty, private
orthopedic groups, like any independent service provider, have
been put at significant at risk. That said, with the assistance of in-
dustry, private practice groups supporting orthopedic hospitals and
physician-owned ambulatory surgery centers may have enhanced
logistical mobility to ramp up elective case load at a greater rate
than hospital-employed or academic orthopedic surgeons. The ul-
timate sustainability of private orthopedic practices must come
through a resumption of normal business practices. In the mean-
time, favorable financing structures for capital expenditures and
volume-based economic incentives are potential opportunities for
industry partners to help “weather the storm”.
There is also risk moving forward that further interruptions in
business could be anticipated in the fourth quarter. Some epide-
miologists and infectious disease experts have predicted that
COVID-19 infections will drop precipitously over the summer, only
to come roaring back in the late fall and winter [2]. Hospitals will
inevitably shoulder the burden of treating infected patients, as they
have currently. Site of care including outpatient surgery centers and
physician-owned hospitals will likely be the “clean” hospitals
moving forward. These sites which will see less viral burden can
serve a public role without placing additional stress on hospital
systems. In anticipation, industry could play a large role in helping
orthopedic surgeons maintain care pathways that ultimately
reduce patient exposure to the COVID-19 virus.
Academic Practice Perspective
The academic arthroplasty surgeon faces a different set of po-
tential pitfalls. The “red tape” commonly associated with large
tertiary referral centersmay obviate the ability to increaseweekday
efforts or add weekend shifts. A push for efficiency may also have
an extended impact on teaching at academic institutions, wanting
to catch up onwait-lists and make up for lost revenue, as a priority
over technical instruction.
Vendor supportmay be limited because of more stringent access
restrictions in tertiary hospitals where COVID-19 patients are still
popping up even after the initial surge has abated. Furthermore, at
many institutions, there is no contract with one or two manufac-
turers, but rather a capitation model with a multitude of vendors
used for primary and revision joint surgery. It is possible that owing
to the financial blow of COVID-19, the model currently in place is
urged to change to produce more savings on implant costs. Finally,
the confidence that there is no risk of coronavirus transmissionwill
need to be instilled in the patients proceeding to elective surgery,
which may be more difficult at a tertiary care center. Whether this
involves increased testing, antibody testing, or advanced PPE usage
is uncertain.
Hospital-Employed Practice Perspective
Much like the position of an academic surgeon, the hospital-
employed orthopedic surgeon may have to a degree had a bufferagainst the immediate economic ramifications of COVID-19 fallout.
This group, however, will have highly variable hospital/adminis-
trative response in the comingmonths. The industry may be able to
play a role in partnering with hospitals to strengthen a previously
existing relationship or forge a new partnership. While the
hospital-employed practice is unlikely to be inundated with a surge
of semi-urgent revision or infection cases compared with a tertiary
referral center, control over when and how to increase production
is variable and administration dependent.
As surgical moratoriums are lifted, it is likely that hospital sys-
tems will place an emphasis on the rapid resumption of highly
profitable elective cases such as total joint arthroplasty to offset
fiscal losses imposed by the COVID-19 shutdown [3]. Favorable
financing structures for capital expenditures and volume based
economic incentives are potential opportunities for industry part-
ners to work with hospital systems to support the hospital-
employed orthopedic surgeon.Conclusions
In summary, most AAHKS industry partner responses indicated
a forward-thinking mindset in the face of COVID-19-induced un-
certainty. In the short term, emphasis on educational offerings has
not been lost, but has been transitioned to a less hands on andmore
technologically driven “social-distancing” friendly medium. This
may very well become a significant aspect of our profession’s “new
normal”. Support for “hands on” training that is a stalwart of total
joint arthroplasty education will likely rebound but may take time
and patience.
It is apparent that arthroplasty surgeons and industry will have
to maximize their efforts to work together safely, cohesively,
respectfully, and efficiently more than ever before, to weather the
tidal wave of surgeries that is sure to come and forge a stronger
working relationship and fortify our profession. Early and open
communicationwill be paramount to smoothly adapt to changes in
volume and disparate needs of surgeons and practices moving
forward.
Orthopedic surgeons, hospitals, and most importantly patients
across the United States have benefited greatly from symbiotic
partnerships with manufacturers of orthopedic products and im-
plants. Although the current pandemic threatens massive upheaval
across the industry, it also provides an opportunity to strengthen
the surgeon-industry partnership in 2020 and beyond, enhancing
our ability to achieve our ultimate goaldthe assurance of access to
quality orthopedic care for the American public.References
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